Sanos Group has launched Nuumi, a technology-enhanced smoking cessation platform that targets both the physical and psychological aspects of nicotine addiction. It combats the issue by combining nicotine replacement technology with a behavior change program. The innovative approach includes a smart vaporizer that delivers personalized nicotine replacement therapy, gradually decreasing nicotine intake. Simultaneously, a companion app offers a behavior change program based on mind-body interventions. This holistic solution aims to eliminate physical and psychological withdrawal symptoms, ensuring a seamless and personalized experience for users.
The startup, founded in 2020, operates in the Health Care industry and secured a €250.00K in its Pre Seed Round investment on 07 January 2020. The lack of specified headquarters and known investors suggests potential opportunities for partnerships and continued funding. Nuumi's unique value proposition and focus on therapy engagement and completion could make it an attractive investment opportunity for venture capitalists looking to support innovative healthcare solutions.
